Vivozon Healthcare Inc (082800) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.055x

Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.055x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.41 Billion ≈ $-3.67 Million USD) by net assets (₩97.74 Billion ≈ $66.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 082800 equity to assets ratio to measure how much of total assets are equity-financed.

Vivozon Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Vivozon Healthcare Inc to evaluate the quality of earnings relative to operating cash generation.

Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Western Investment Company of Canada Limited V:WI	0.074x
Winpac Inc KQ:097800	0.123x
D&D Platform Reit Co Ltd KO:377190	N/A
Quintain Steel Co Ltd TW:2017	0.005x
Air Busan Co Ltd KO:298690	0.154x
M.C.S. Steel Public Company Limited BK:MCS	0.055x
ABL GROUP ASA NA NK-10 F:26Q	-0.043x
The Joint Corp NASDAQ:JYNT	-0.095x

Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see 082800 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩72.66 Billion ≈ $49.24 Million	₩-6.87 Billion ≈ $-4.65 Million	-0.095x	-275.53%
2024-12-31	₩106.43 Billion ≈ $72.12 Million	₩5.73 Billion ≈ $3.88 Million	0.054x	+87.33%
2023-12-31	₩104.07 Billion ≈ $70.52 Million	₩2.99 Billion ≈ $2.03 Million	0.029x	+191.55%
2022-12-31	₩105.84 Billion ≈ $71.72 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.031x	+84.72%
2021-12-31	₩85.12 Billion ≈ $57.68 Million	₩-17.50 Billion ≈ $-11.86 Million	-0.206x	-579.12%
2020-12-31	₩107.80 Billion ≈ $73.06 Million	₩4.62 Billion ≈ $3.13 Million	0.043x	+220.09%
2019-12-31	₩109.00 Billion ≈ $73.87 Million	₩-3.89 Billion ≈ $-2.64 Million	-0.036x	+46.71%
2018-12-31	₩68.45 Billion ≈ $46.38 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.067x	+76.48%
2017-12-31	₩16.10 Billion ≈ $10.91 Million	₩-4.59 Billion ≈ $-3.11 Million	-0.285x	-210.44%
2016-12-31	₩22.74 Billion ≈ $15.41 Million	₩5.87 Billion ≈ $3.98 Million	0.258x	+128.52%
2015-12-31	₩24.65 Billion ≈ $16.71 Million	₩2.78 Billion ≈ $1.89 Million	0.113x	+26.48%
2014-12-31	₩33.90 Billion ≈ $22.97 Million	₩3.03 Billion ≈ $2.05 Million	0.089x	--

About Vivozon Healthcare Inc

KQ:082800 Korea Pharmaceuticals

Market Cap

$118.33 Million

₩174.61 Billion KRW

Market Cap Rank

#18487 Global

#796 in Korea

Share Price

₩2345.00

Change (1 day)

+7.57%

52-Week Range

₩2155.00 - ₩8150.00

All Time High

₩16500.00